These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21647511)

  • 1. A platinum Chugaev carbene complex as a potent anticancer agent.
    Alves G; Morel L; El-Ghozzi M; Avignant D; Legeret B; Nauton L; Cisnetti F; Gautier A
    Chem Commun (Camb); 2011 Jul; 47(27):7830-2. PubMed ID: 21647511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
    Wagner G; Marchant A; Sayer J
    Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual dimeric chemical structure for a carboplatin analogue as a potential anticancer complex.
    Xie M; Liu W; Lou L; Chen X; Ye Q; Yu Y; Chang Q; Hou S
    Inorg Chem; 2010 Jul; 49(13):5792-4. PubMed ID: 20515022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-heterocyclic carbene-amine Pt(II) complexes, a new chemical space for the development of platinum-based anticancer drugs.
    Skander M; Retailleau P; Bourrié B; Schio L; Mailliet P; Marinetti A
    J Med Chem; 2010 Mar; 53(5):2146-54. PubMed ID: 20148592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.
    Margiotta N; Capitelli F; Ostuni R; Natile G
    J Inorg Biochem; 2008 Dec; 102(12):2078-86. PubMed ID: 18760482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
    Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
    Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
    Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
    J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
    Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
    J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
    Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
    J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(IV) coordination compounds containing 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one as nonleaving ligand. Molecular and cytotoxicity in vitro characterization.
    Łakomska I; Fandzloch M; Wojtczak A; Szłyk E
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Aug; 79(3):497-501. PubMed ID: 21536486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
    Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven-membered cycloplatinated complexes as a new family of anticancer agents. X-ray characterization and preliminary biological studies.
    Cortés R; Crespo M; Davin L; Martín R; Quirante J; Ruiz D; Messeguer R; Calvis C; Baldomà L; Badia J; Font-Bardía M; Calvet T; Cascante M
    Eur J Med Chem; 2012 Aug; 54():557-66. PubMed ID: 22770537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.